Franklin O. Smith
- Hematology top 0.2%
- Acute Myeloid Leukemia Research 58
- Hematopoietic Stem Cell Transplantation 39
- Genetics top 1%
-
- Acute Lymphoblastic Leukemia research 37
- Oncology top 2%
- Neutropenia and Cancer Infections 11
-
- Childhood Cancer Survivors' Quality of Life 11
-
- DNA Repair Mechanisms 6
- CRISPR and Genetic Engineering 6
-
- Neuroblastoma Research and Treatments 6
- Co-authors
- Todd A. AlonzoNita L. SeibelGregory H. ReamanRobert B. GerbingSean F. AltekruseAlan S. GamisMalcolm A. SmithMaura O’Leary
- Journals
- Journal of Clinical Investigation (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (11 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Franklin O. Smith
117 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Hematology 2.9k
- Genetics 660
- Public Health, Environmental and Occupational Health 1.8k
- Oncology 1.2k
- Pediatrics, Perinatology and Child Health 877
Countries citing papers authored by Franklin O. Smith
This map shows the geographic impact of Franklin O. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franklin O. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franklin O. Smith more than expected).
Fields of papers citing papers by Franklin O. Smith
This network shows the impact of papers produced by Franklin O. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franklin O. Smith. The network helps show where Franklin O. Smith may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Franklin O. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531breakdown → | 2014 | 313 |
| 2 | 2013 | 11 | |
| 3 | 2013 | 9 | |
| 4 | 2008 | 6 | |
| 5 | 2008 | 12 | |
| 6 | 2008 | 28 | |
| 7 | 2007 | 23 | |
| 8 | 2005 | 31 | |
| 9 | 2005 | 4 | |
| 10 | 2003 | 17 | |
| 11 | Infectious complications of intensive chemotherapy on children's cancer group protocol CCG-2961 for pediatric acute myeloid leukemia | 2002 | 4 |
| 12 | 2002 | 51 | |
| 13 | 2000 | 57 | |
| 14 | 1998 | 12 | |
| 15 | 1996 | 67 | |
| 16 | 1995 | 5 | |
| 17 | 1994 | 124 | |
| 18 | 1967 | 1 | |
| 19 | 1967 | 1 | |
| 20 | 1967 | 1 |
About Franklin O. Smith
Franklin O. Smith is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics, having authored 121 papers that have together received 5.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (58 papers), Hematopoietic Stem Cell Transplantation (39 papers), Acute Lymphoblastic Leukemia research (37 papers), Childhood Cancer Survivors' Quality of Life (11 papers), Neutropenia and Cancer Infections (11 papers), DNA Repair Mechanisms (6 papers), CRISPR and Genetic Engineering (6 papers) and Neuroblastoma Research and Treatments (6 papers). The work is most often cited by research in Hematology (2.9k citations), Genetics (660 citations) and Public Health, Environmental and Occupational Health (1.8k citations). Franklin O. Smith has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Todd A. Alonzo, Nita L. Seibel, Gregory H. Reaman, Robert B. Gerbing, Sean F. Altekruse, Alan S. Gamis, Malcolm A. Smith, Maura O’Leary, Lynn A. G. Ries and Beverly J. Lange. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.